Shaperon샤페론
378800 · KOSDAQ · ₩378800 · 샤페론
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩1,113
vs the current price (₩2,350)
- Enterprise value
- −₩7.9B
- Equity value
- ₩10B
- WACC
- 7.4%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 53% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- No operating margin up to 90% gets the model to today's price at these growth assumptions.
- Margins ranged from −85,523.5% to −551.5% over the last 4 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩1,301
- −44.7%
- Base
- ₩1,113
- −52.6%
- Bull
- ₩833
- −64.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Start from
Preliminary results are the company's early announcement of a quarter's sales and operating profit, before the full report. Including them swaps that quarter in for the same quarter a year earlier.
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- -10%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-51.5% a year, annual reports), fading to 3% by year 5.
- -6.7%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-51.5% a year, annual reports), fading to 3% by year 5.
- -3.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-51.5% a year, annual reports), fading to 3% by year 5.
- -0.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-51.5% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-51.5% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 4 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 1,136.4%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 1,420.5%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.25, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩323M
- Net debt (borrowings and leases − cash and deposits)
- −₩18B
- Shares
- 9,248,606
- Share price
- ₩2,350
- Market cap
- ₩22B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩215M | ₩18M | ₩228M | ₩290M | ₩271M | ₩261M | ₩261M | ₩269M |
| Growth | −89.2% | −91.8% | 1,186.7% | −10.0% | −6.7% | −3.5% | −0.2% | 3.0% |
| EBIT | −₩13B | −₩15B | −₩16B | −₩58M | −₩54M | −₩52M | −₩52M | −₩54M |
| EBIT margin | −6,145.5% | −85,523.5% | −6,952.9% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩9.6B | −₩11B | −₩11B | −₩42M | −₩39M | −₩38M | −₩38M | −₩39M |
| + Depreciation | — | — | — | ₩3.3B | ₩3.1B | ₩3B | ₩3B | ₩3.1B |
| − Capital spending | ₩1.9B | ₩564M | ₩405M | ₩4.1B | ₩3.8B | ₩3.7B | ₩3.7B | ₩3.8B |
| − Working capital | −₩27B | −₩454M | −₩71M | ₩3.2M | ₩1.9M | ₩948,030 | ₩52,277 | −₩782,588 |
| Free cash flow | — | — | — | −₩870M | −₩811M | −₩781M | −₩779M | −₩802M |
| Discount factor | — | — | — | 0.931 | 0.867 | 0.808 | 0.752 | 0.700 |
| Present value | — | — | — | −₩810M | −₩703M | −₩631M | −₩586M | −₩561M |
Terminal value −₩6.5B, worth −₩4.6B today: 58% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩2,057 a share)Now 1.14× | ₩2,5351.23× | ₩14,3136.96× | ₩25,47712.4× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2023, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.4% | ₩1,085 | ₩1,030 | ₩962 | ₩877 | ₩767 |
| 6.9% | ₩1,144 | ₩1,099 | ₩1,045 | ₩979 | ₩895 |
| 7.4% | ₩1,194 | ₩1,157 | ₩1,113 | ₩1,060 | ₩995 |
| 7.9% | ₩1,238 | ₩1,207 | ₩1,170 | ₩1,127 | ₩1,075 |
| 8.4% | ₩1,275 | ₩1,249 | ₩1,218 | ₩1,183 | ₩1,140 |
Now (TTM)
- Market cap
- ₩22B
- Enterprise value
- ₩3.6B
- P/E
- —
- P/B
- 1.1×
- P/S
- 67.4×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Price | ₩8,700 | ₩15,395 | ₩16,538 | ₩31,229 |
| Market cap | ₩80B | ₩142B | ₩153B | ₩289B |
| P/E | — | — | — | — |
| P/B | 3.3× | 8.9× | 8.1× | 9.9× |
| P/S | 353.2× | 8,042.0× | 710.6× | 144.4× |
| EV/EBITDA | — | — | — | — |
| Dividend yield | 0.0% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Shaperon | — | 1.1× | 67.4× | — | 0.0% |
| Samsung Biologics | 32.0× | 7.6× | 14.0× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 80.5× | 29.0× | 61.2× | — | 0.1% |
| SK biopharmaceuticals | 14.7× | 5.8× | 6.8× | — | 0.0% |
| Yuhan | 24.0× | 2.4× | 2.5× | 31.3× | 0.8% |
| HLB | — | 15.7× | 55.6× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.7× | 11.5× | 31.3× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Shaperon / 샤페론 / 378800 / KRX:378800
Source: KRX statistical information